Glucagon-like peptide 2, a product of glucagon gene expression, and
analogs of glucagon-like peptide 2, have been identified as gastrointestinal tissue
growth factors. Their effects on the growth of small bowel and pancreatic islets
are described. Their formulation as a pharmaceutical, and their therapeutic use
in treating disorders of the bowel, are described.